• The client’s product portfolio resides primarily in the pharmacy benefit space with the exception of a recently launched medical benefit drug
  • Relationships with payers were primarily with P&T, formulary and financial decision makers focusing on contracting and pull through
  • Client wanted to establish their medical benefit product as the new standard of care for appropriate patients and differentiate the product from anticipated competitive launches


  • The VSHG Executive Director (ED) worked to identify key payer initiatives and medical benefit decision making process in the product therapeutic area
  • The VSHG Medical Benefit ED worked through existing plan contacts to identify the medical directors shaping policy decisions and driving therapeutic area initiatives
  • VSHG ED attended conferences sponsored by the national payer as well as set up introductory meetings through plan contacts with key medical directors


  • VSHG ED set up engagement meetings for client senior leadership as well as client account managers with seven Medical Directors or VPs in the therapeutic space
  • VSHG ED developed a project to have the client a sponsor therapeutic area thought leader speaker at the national payer’s sponsored conference

Scroll to Top